Diabetes Technology and Therapeutics

eISSN: 1557-8593pISSN: 1520-9156

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
10.3
Eigenfactor
0.005 - 0.01
H-Index
97
Impact Factor
5 - 10
SJR
Q1Endocrinology
SNIP
1.97

Journal Specifications

Overview
  • Publisher
    MARY ANN LIEBERT, INC
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Quality of life
Hypoglycemia
Continuous glucose monitoring
Type 2 diabetes
Clinical trial
Exercise
Randomized controlled trial
Health care
Artificial intelligence
Insulin pump
Standard deviation
Type 2 Diabetes Mellitus
Nonalcoholic fatty liver disease
Insulin delivery
Intensive care unit
Diabetic ketoacidosis
Diabetes management
Insulin dose
Interquartile range
Feasibility study

Recently Published Papers

Year-wise Publication

FAQs

Since when has Diabetes Technology and Therapeutics been publishing? Faqs

The Diabetes Technology and Therapeutics has been publishing since 1999 till date.

How frequently is the Diabetes Technology and Therapeutics published? Faqs

Diabetes Technology and Therapeutics is published Monthly.

What is the H-index. SNIP score, Citescore and SJR of Diabetes Technology and Therapeutics? Faqs

Diabetes Technology and Therapeutics has a H-index score of 97, Citescore of 10.3, SNIP score of 1.97, & SJR of Q1

Who is the publisher of Diabetes Technology and Therapeutics? Faqs

The publisher of Diabetes Technology and Therapeutics is MARY ANN LIEBERT, INC.

How can I view the journal metrics of Diabetes Technology and Therapeutics on editage? Faqs

For the Diabetes Technology and Therapeutics metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Diabetes Technology and Therapeutics? Faqs

The eISSN number is 1557-8593 and pISSN number is 1520-9156 for Diabetes Technology and Therapeutics.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Quality of life, Hypoglycemia, Continuous glucose monitoring, Type 2 diabetes, Clinical trial, Exercise, Randomized controlled trial, Health care, Artificial intelligence, Insulin pump, Standard deviation, Type 2 Diabetes Mellitus, Nonalcoholic fatty liver disease, Insulin delivery, Intensive care unit, Diabetic ketoacidosis, Diabetes management, Insulin dose, Interquartile range, Feasibility study.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.